"Designing Growth Strategies is in our DNA"

U.S. In-vitro Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, and Others), By Setting (Laboratories and Point of Care), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, and Others), By End-user (Clinical Laboratories, Hospitals, Physician’s Offices, and Others), and Forecasts, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI107584

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases in the U.S., 2021/2022
    2. New Product Launches by Key Players
    3. Recent Industry Developments - Mergers & Acquisitions
    4. Overview of Healthcare Expenditure in the U.S.
    5. Technological Advancements
    6. Key Industry Trends
    7. Impact of COVID-19 on the In-Vitro Diagnostics Market
  5. U.S. In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
      2. Clinical Chemistry
      3. Molecular Diagnostics
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physicians Offices
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Abbott
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Quest Diagnostics Incorporated
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Bio Rad Laboratories, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. BD
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Agilent Technologies, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Quidel Corporation
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Siemens Healthcare GmbH
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. In-Vitro Diagnostics Market Value Share (%), by Product Type, 2022 & 2030

Figure 2:  U.S. In-Vitro Diagnostics Market Value Share (%), by Technique, 2022 & 2030

Figure 3:  U.S. In-Vitro Diagnostics Market Value Share (%), by Setting, 2022 & 2030

Figure 4:  U.S. In-Vitro Diagnostics Market Value Share (%), by Application, 2022 & 2030

Figure 5:  U.S. In-Vitro Diagnostics Market Value Share (%), by End-user, 2022 & 2030

Figure 6:  U.S. In-Vitro Diagnostics Market Share (%), By Company, 2022 

Table 1:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2019–2030

Table 2:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019–2030

Table 3:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2019–2030

Table 4:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2019–2030

Table 5:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by End-user 2019–2030

U.S. In-vitro Diagnostics Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 160
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase